Feasability of biowaiver extension to ciprofloxacin

• In: SIG: Dissolution/In Vitro Release Performance Testing - Posters
• At: Basel (Switzerland) (2008)
• Type: Poster
• Poster code: DIV-P-001
• By: KYRIACOS, Soula (Lebanese American University, Byblos, Lebanon)
• Co-author(s): Safi, William (Lebanese American University, BYBLOS, Lebanon)
  Boukarim, Chawki (Lebanese American University, BYBLOS, Lebanon)
  Mroueh, Mohamad (Lebanese American University, BYBLOS, Lebanon)
  Bou Maroun, Aline (Lebanese American University, BYBLOS, Lebanon)
  El-Khoury, Ghada (Lebanese American University, BYBLOS, Lebanon)
  Shehayeb, Rabih (Lebanese American University, BYBLOS, Lebanon)
  
• Abstract:

  Ciprofloxacin is a widely prescribed synthetic quinolone antiinfective agent. Health professionals are confronted with a wide choice of multi-source generics, imported and locally produced. These generics are available at significant price differences with one generic costing 24 times less than the brand product. Due to the importance of..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login